Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer

Ai zheng = Aizheng = Chinese journal of cancer

Volumn 27, Issue 10, 2008, Pages 1077-1081

  Lin, Qiang ^a   Gao, Xian Shu ^b   Qiao, Xue Ying ^b   Chen, Kun ^b   Wang, Ya Di ^b   Zhou, Zhi Guo ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; REMISSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION PNEUMONITIS; REMISSION INDUCTION; SURVIVAL RATE;

EID: 77956085647     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)